Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4

por Ohar, Jill, Tosiello, Robert, Goodin, Thomas, Sanjar, Shahin
Publicado 2018

Dose selection for glycopyrrolate/eFlow(®) phase III clinical studies: results from GOLDEN (Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer) phase II dose-find...

por Donohue, James F., Goodin, Thomas, Tosiello, Robert, Wheeler, Alistair
Publicado 2017

Effect of background long-acting beta(2)-agonist therapy on the efficacy and safety of a novel, nebulized glycopyrrolate in subjects with moderate-to-very-severe COPD

por Kerwin, Edward M, Tosiello, Robert, Price, Barry, Sanjar, Shahin, Goodin, Thomas
Publicado 2018

One-Year Safety and Efficacy Study of Arformoterol Tartrate in Patients With Moderate to Severe COPD

por Donohue, James F., Hanania, Nicola A., Make, Barry, Miles, Matthew C., Mahler, Donald A., Curry, Lisa, Tosiello, Robert, Wheeler, Alistair, Tashkin, Donald P.
Publicado 2014